9-69248319-A-G

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The ENST00000636247.1(TJP2):​n.3054A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0778 in 1,484,356 control chromosomes in the GnomAD database, including 4,799 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.071 ( 432 hom., cov: 32)
Exomes 𝑓: 0.079 ( 4367 hom. )

Consequence

TJP2
ENST00000636247.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.522

Publications

8 publications found
Variant links:
Genes affected
TJP2 (HGNC:11828): (tight junction protein 2) This gene encodes a zonula occluden that is a member of the membrane-associated guanylate kinase homolog family. The encoded protein functions as a component of the tight junction barrier in epithelial and endothelial cells and is necessary for proper assembly of tight junctions. Mutations in this gene have been identified in patients with hypercholanemia, and genomic duplication of a 270 kb region including this gene causes autosomal dominant deafness-51. Alternatively spliced transcripts encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Nov 2011]
TJP2 Gene-Disease associations (from GenCC):
  • cholestasis, progressive familial intrahepatic, 4
    Inheritance: AR Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet
  • familial hypercholanemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen
  • hypercholanemia, familial 1
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.018).
BP6
Variant 9-69248319-A-G is Benign according to our data. Variant chr9-69248319-A-G is described in ClinVar as [Benign]. Clinvar id is 44109.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.081 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TJP2NM_004817.4 linkc.2880+95A>G intron_variant Intron 19 of 22 ENST00000377245.9 NP_004808.2 Q9UDY2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TJP2ENST00000377245.9 linkc.2880+95A>G intron_variant Intron 19 of 22 1 NM_004817.4 ENSP00000366453.4 Q9UDY2-1
ENSG00000285130ENST00000642889.1 linkc.3267+95A>G intron_variant Intron 21 of 24 ENSP00000493780.1 A0A2R8YDH4

Frequencies

GnomAD3 genomes
AF:
0.0711
AC:
10824
AN:
152130
Hom.:
430
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0559
Gnomad AMI
AF:
0.0592
Gnomad AMR
AF:
0.0600
Gnomad ASJ
AF:
0.0562
Gnomad EAS
AF:
0.00598
Gnomad SAS
AF:
0.0854
Gnomad FIN
AF:
0.103
Gnomad MID
AF:
0.0601
Gnomad NFE
AF:
0.0828
Gnomad OTH
AF:
0.0771
GnomAD2 exomes
AF:
0.0661
AC:
6723
AN:
101664
AF XY:
0.0687
show subpopulations
Gnomad AFR exome
AF:
0.0522
Gnomad AMR exome
AF:
0.0421
Gnomad ASJ exome
AF:
0.0601
Gnomad EAS exome
AF:
0.00651
Gnomad FIN exome
AF:
0.0900
Gnomad NFE exome
AF:
0.0817
Gnomad OTH exome
AF:
0.0642
GnomAD4 exome
AF:
0.0786
AC:
104690
AN:
1332108
Hom.:
4367
Cov.:
33
AF XY:
0.0791
AC XY:
51273
AN XY:
648358
show subpopulations
African (AFR)
AF:
0.0558
AC:
1658
AN:
29688
American (AMR)
AF:
0.0424
AC:
1155
AN:
27266
Ashkenazi Jewish (ASJ)
AF:
0.0590
AC:
1217
AN:
20628
East Asian (EAS)
AF:
0.00299
AC:
105
AN:
35090
South Asian (SAS)
AF:
0.0884
AC:
5994
AN:
67784
European-Finnish (FIN)
AF:
0.0929
AC:
4351
AN:
46820
Middle Eastern (MID)
AF:
0.0828
AC:
444
AN:
5364
European-Non Finnish (NFE)
AF:
0.0820
AC:
85662
AN:
1044482
Other (OTH)
AF:
0.0746
AC:
4104
AN:
54986
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
5450
10900
16350
21800
27250
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3250
6500
9750
13000
16250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0712
AC:
10837
AN:
152248
Hom.:
432
Cov.:
32
AF XY:
0.0719
AC XY:
5350
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.0560
AC:
2328
AN:
41558
American (AMR)
AF:
0.0599
AC:
915
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0562
AC:
195
AN:
3472
East Asian (EAS)
AF:
0.00580
AC:
30
AN:
5172
South Asian (SAS)
AF:
0.0855
AC:
412
AN:
4818
European-Finnish (FIN)
AF:
0.103
AC:
1089
AN:
10610
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.0828
AC:
5632
AN:
68018
Other (OTH)
AF:
0.0768
AC:
162
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
517
1033
1550
2066
2583
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0745
Hom.:
1497
Bravo
AF:
0.0669
Asia WGS
AF:
0.0430
AC:
151
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 21, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

His992Arg in Exon 19 of TJP2: This variant is not expected to have clinical sign ificance because it has been identified in 6.9% (174/2532) of European American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs77236826). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.42
DANN
Benign
0.23
PhyloP100
-0.52
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77236826; hg19: chr9-71863235; COSMIC: COSV55266203; COSMIC: COSV55266203; API